Q3 2024

Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001493152-24-045717

Q3 2024 · 10-Q

Revenue

$15.44K

+320.1% vs Q3 2023

Net Income

-$77.20K

N/M vs Q3 2023

EPS Diluted

$0.00

— vs Q3 2023

Gross Profit-$14,884N/M

Operating Income

Same quarter

Metric	Q3 2024	Q3 2023	Q3 2019	Q3 2018
Revenue	$15.44K	$3.68K	$0.00	$0.00
Net Income	-$77.20K	-$141.02K	-$17.97K	-$21.81K
EPS Diluted	$0.00	$0.00	-$0.01	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR